CCTA demonstrates soft coronary plaque regression following lipid-lowering therapy
Cardiovascular Business
CCTA reveals a significant finding: soft coronary plaque regression after lipid-lowering therapy.
Cardiovascular Business
CCTA reveals a significant finding: soft coronary plaque regression after lipid-lowering therapy.